Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd. et al > Documents

Date Field	Doc. No.	Description (Pages)
Apr 13, 2020	416	USCA Mandate (1) Docket Text: MANDATE of USCA as to [404] Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd., [399] Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. Appeal [404], [399] Terminated (Paine, Matthew)
Mar 5, 2020	415	USCA Judgment (2) Docket Text: USCA Judgment for the Federal Circuit as to [404] Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd., [399] Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. AFFIRMED... (Paine, Matthew)
Jan 24, 2020	414	Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Appearance of Elizabeth A. Cutri by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. Notice of Withdrawal of Attorney Elizabeth A. Cutri (Martin, Andrea) Modified on 1/27/2020 to edit description of filing (Montes, Mariliz).
Nov 25, 2019	412	Order on Motion to Unseal Document (1) Docket Text: Judge Mark L. Wolf: ORDER entered granting [410] Joint Motion to Unseal Portions of the Record. (Loret, Magdalena)
Nov 25, 2019	413	Order (2) Docket Text: Judge Mark L. Wolf: ORDER entered re [411] Order Unsealing Portions of the Record.(Loret, Magdalena)
Oct 17, 2019	410	Main Document (5) Docket Text: Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # (1) Dkt. No. 15-9, # (2) Dkt. No. 15-10, # (3) Dkt. No. 15-11, # (4) Dkt. No. 306-2, # (5) Dkt. No. 306-4, # (6) Dkt. No. 306-5, # (7) Dkt. No. 340-2 (15-cv-10698), # (8) Dkt. No. 340-3 (15-cv-10698), # (9) Dkt. No. 343-1 (15-cv-10698), # (10) Dkt. No. 15-2, # (11) Dkt. No. 15-5, # (12) Dkt. No. 227, # (13) Dkt. No. 260-12, # (14) Dkt. No. 306-1)(Casey, Alison)
Oct 17, 2019	410	Dkt. No. 15-9 (8)
Oct 17, 2019	410	Dkt. No. 15-10 (7)
Oct 17, 2019	410	Dkt. No. 15-11 (16)
Oct 17, 2019	410	Dkt. No. 306-2 (6)
Oct 17, 2019	410	Dkt. No. 306-4 (5)
Oct 17, 2019	410	Dkt. No. 306-5 (6)
Oct 17, 2019	410	Dkt. No. 340-2 (15-cv-10698) (15)
Oct 17, 2019	410	Dkt. No. 340-3 (15-cv-10698) (30)
Oct 17, 2019	410	Dkt. No. 343-1 (15-cv-10698) (15)
Oct 17, 2019	410	Dkt. No. 15-2 (48)
Oct 17, 2019	410	Dkt. No. 15-5 (12)
Oct 17, 2019	410	Dkt. No. 227 (39)
Oct 17, 2019	410	Dkt. No. 260-12 (97)
Oct 17, 2019	410	Dkt. No. 306-1 (11)
Oct 17, 2019	411	Proposed Document(s) submitted (2) Docket Text: Proposed Document(s) submitted by Janssen Biotech, Inc.. Document received: Proposed Order Unsealing Portions of the Record [D.I. 410]. (Casey, Alison)
Jul 22, 2019	409	Motion to Withdraw as Attorney (3) Docket Text: Notice of Withdrawal of Counsel - Daniel A. Friedman by Janssen Biotech, Inc..(Friedman, Daniel) Modified on 7/24/2019 to edit description of pleading(Montes, Mariliz).
Jun 19, 2019	408	Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by Irena Royzman (Royzman, Irena)
Sep 10, 2018	407	USCA Case Number (1) Docket Text: USCA Case Number 18-2350 for [404] Cross Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd.. (Paine, Matthew)
Sep 4, 2018	406	Abbreviated Electronic Record on Appeal Sent to USCA (1) Docket Text: Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re [404] Cross Notice of Appeal to the Federal Circuit. (Paine, Matthew)
Aug 31, 2018	402	USCA Case Number (1) Docket Text: USCA Case Number 18-2321 for [399] Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. (Paine, Matthew)
Aug 31, 2018	403	Notice of Cross Appeal (3) Docket Text: NOTICE OF CROSS APPEAL as to [397] Judgment by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. ( Filing fee: $ 505, receipt number 0101-7299772 (Fee Status: Filing Fee paid)) NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov MUST be completed and submitted to the Court of Appeals. Counsel shall register for a First Circuit CM/ECF Appellate Filer Account at http://pacer.psc.uscourts.gov/cmecf. Counsel shall also review the First Circuit requirements for electronic filing by visiting the CM/ECF Information section at http://www.ca1.uscourts.gov/efiling.htm. US District Court Clerk to deliver official record to Court of Appeals by 9/20/2018. (Martin, Andrea)
Aug 31, 2018	404	Notice of Appeal to the Federal Circuit (3) Docket Text: CROSS NOTICE OF APPEAL to the Federal Circuit as to [397] Judgment, [62] Memorandum & ORDER by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. US District Court Clerk to deliver official record to Court of Appeals by 9/20/2018.( Filing fee: $ 505, receipt number 0101-7299772 (Fee Status: Filing Fee paid) (Paine, Matthew)
Aug 31, 2018	N/A	Notice of correction to docket made by Court staff (0) Docket Text: Notice of correction to docket made by Court staff. Correction: Docket Entry [403] Cross Notice of Appeal to the Federal Circuit Corrected Because: The Cross Notice of Appeal to the Federal Circuit Was Filed Under The Wrong Event By Counsel Martin. The Cross Notice of Appeal Was Re-Filed Under the Correct Event as ECF No. [404] and the Appeal to the First Circuit Court of Appeals Terminated. (Paine, Matthew)
Aug 27, 2018	401	Abbreviated Electronic Record on Appeal Sent to USCA (1) Docket Text: Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re [399] Notice of Appeal to the Federal Circuit by Janssen Biotech, Inc.. (Paine, Matthew)
Aug 24, 2018	399	Notice of Appeal to the Federal Circuit (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit as to [397] Judgment, [393] Order on Motion for Summary Judgment,(Filing fee: $ 505, receipt number 0101-7289422 Fee Status: Not Exempt. ) by Janssen Biotech, Inc. US District Court Clerk to deliver official record to Court of Appeals by 9/13/2018. (Paine, Matthew)
Aug 24, 2018	N/A	Notice of correction to docket made by Court staff (0) Docket Text: Notice of correction to docket made by Court staff. Correction: Docket Entry [398] Notice of Appeal to the Federal Circuit corrected because: The Notice of Appeal to the Federal Circuit Was Filed Under The Wrong Event By Counsel Repicky. The Notice of Appeal Was Re-Filed Under the Correct Event as ECF No. [399] and the Appeal to the First Circuit Court of Appeals Terminated. (Paine, Matthew)
Aug 24, 2018	399	Notice of Appeal* (1)
Aug 23, 2018	396	Order on Motion to Amend (2) Docket Text: Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion to Amend the Judgment (Docket No. 395) is ALLOWED. An Amended Judgment shall enter for defendants on: (a) plaintiff's Counts 1, 2, 3, 4, and 5 and counterclaim Counts 1 and 2, claiming infringement of the '083 patent; and (b) defendants' first counterclaim, seeking a declaration that defendants have not infringed the '083 patent. 2. Defendants' second counterclaim, seeking a declaration that the '083 patent is invalid and/or unenforceable, is DISMISSED without prejudice." ORDER entered granting [395] Motion to Amend (Bono, Christine)
Aug 23, 2018	397	Judgment (1) Docket Text: Judge Mark L. Wolf: ORDER entered. AMENDED JUDGMENT. (Bono, Christine)
Aug 23, 2018	398	Notice of Appeal (2) Docket Text: NOTICE OF APPEAL as to [397] Judgment, [393] Order on Motion for Summary Judgment, by Janssen Biotech, Inc. Filing fee: $ 505, receipt number 0101-7289422 Fee Status: Not Exempt. NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov MUST be completed and submitted to the Court of Appeals. Counsel shall register for a First Circuit CM/ECF Appellate Filer Account at http://pacer.psc.uscourts.gov/cmecf. Counsel shall also review the First Circuit requirements for electronic filing by visiting the CM/ECF Information section at http://www.ca1.uscourts.gov/cmecf. US District Court Clerk to deliver official record to Court of Appeals by 9/12/2018. (Repicky, Heather)
Aug 23, 2018	398	Notice of Appeal* (1)
Aug 22, 2018	395	Motion to Amend (4) Docket Text: MOTION to Amend [394] Judgment Under FRCP 59(e) and/or 60(a) and to Dismiss Without Prejudice Defendants' Invalidity Counterclaim - Unopposed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jul 31, 2018	394	Judgment (1) Docket Text: Judge Mark L. Wolf: ORDER entered. JUDGMENT. (Bono, Christine)
Jul 30, 2018	393	Main Document (104) Docket Text: Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is ALLOWED. 2. Judgment shall enter for the defendants." MEMORANDUM AND ORDER entered granting [226] Motion for Summary Judgment (Attachments: # (1) Exhibit 1, # (2) Exhibit 2) (Bono, Christine)
Jul 30, 2018	393	Exhibit 1 (4)
Jul 30, 2018	393	Exhibit 2 (5)
Jul 27, 2018	391	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Leslie M. Schmidt, Samuel Blake and Sharre Lotfollahi Filing fee: $ 300, receipt number 0101-7249545 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Affidavit of Leslie M. Schmidt, # (2) Affidavit of Samuel Blake, # (3) Affidavit of Sharre Lotfollahi)(Martin, Andrea)
Jul 27, 2018	391	Affidavit of Leslie M. Schmidt (2)
Jul 27, 2018	391	Affidavit of Samuel Blake (2)
Jul 27, 2018	391	Affidavit of Sharre Lotfollahi (2)
Jul 27, 2018	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [391] Motion for Leave to Appear Pro Hac Vice Added Leslie M. Schmidt, Samuel Blake, Sharre Lotfollahi. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Jul 26, 2018	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [388] Motion for Leave to Appear Pro Hac Vice Added Nikhil R. Krishnan. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Jul 26, 2018	N/A	Order on Motion for Extension of Time to File Response/Reply (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWING [387] MOTION for Extension of Time to 8/1/18 to File Response/Reply as to [384] Memorandum in Support of Motion, Plaintiff assented to 7/31/18 only Responses due by 8/1/2018. (Franklin, Yvonne)
Jul 25, 2018	388	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Nikhil R. Krishnan Filing fee: $ 100, receipt number 0101-7246106 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Affidavit of Nikhil R. Krishnan)(Martin, Andrea) (Attachment 1 replaced on 7/26/2018) (Franklin, Yvonne). Modified on 7/26/2018 to correct document. (Franklin, Yvonne).
Jul 25, 2018	388	Affidavit of Nikhil R. Krishnan (2)
Jul 19, 2018	387	Motion for Extension of Time to File Response/Reply (3) Docket Text: MOTION for Extension of Time to 8/1/18 to File Response/Reply as to [384] Memorandum in Support of Motion, Plaintiff assented to 7/31/18 only by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jul 13, 2018	383	Motion for Discovery (3) Docket Text: MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco by Janssen Biotech, Inc..(Casey, Alison)
Jul 13, 2018	384	Main Document (23) Docket Text: MEMORANDUM in Support re [383] MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1-5 (Filed Under Seal), # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Casey, Alison)
Jul 13, 2018	384	Exhibit 1-5 (Filed Under Seal) (1)
Jul 13, 2018	384	Exhibit 6 (69)
Jul 13, 2018	384	Exhibit 7 (105)
Jul 13, 2018	384	Exhibit 8 (3)
Jul 13, 2018	385	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Exhibits 1-5 Accompanying Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco by Janssen Biotech, Inc..(Casey, Alison)
Jun 29, 2018	382	Letter/request (non-motion) (1) Docket Text: Letter/request (non-motion) from Gregory L. Diskant regarding anticipated motion to reopen damages case.. (Diskant, Gregory)
Jun 28, 2018	380	Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Both Parties re: Scheduling. (Martin, Andrea)
Jun 28, 2018	381	Order (2) Docket Text: Judge Mark L. Wolf: "[I]t is hereby ORDERED that: 1. If the pending motion for summary judgment on ensnarement is denied, a telephone conference will be held to discuss plaintiff's intention to seek leave to amend its damages claims and scheduling issues. 2. Unless otherwise ordered, if the motion for summary judgment on ensnarement is denied, hearings on pretrial motions will begin on August 6, 2018, and trial will commence on August 27, 2018. 3. The parties shall continue to confer and, by 12:00 noon on July 6, 2018, report whether they have agreed to a resolution of this case." ORDER entered. (Bono, Christine)
Jun 22, 2018	375	Main Document (1) Docket Text: Letter/request (non-motion) from Gregory Diskant regarding WesternGeco LLC v. Ion Geophysical Corp. (Attachments: # (1) Exhibit A)(Casey, Alison)
Jun 22, 2018	375	Exhibit A (21)
Jun 18, 2018	372	Main Document (9) Docket Text: Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to [368] Brief re Novelty and Non-Obviousness. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jun 18, 2018	372	Exhibit 1 (5)
Jun 18, 2018	372	Exhibit 2 (5)
Jun 15, 2018	N/A	Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah)
Jun 14, 2018	367	Order (1) Docket Text: Judge Mark L. Wolf: "As stated in court on June 13, 2018, it is hereby ORDEREDthat the parties shall, by June 20, 2018, confer and report concerning the status of this case." ORDER entered. (Bono, Christine)
Jun 14, 2018	368	Brief (5) Docket Text: BRIEF by Janssen Biotech, Inc. Janssen's Supplemental Submission Regarding Novelty and Non-Obviousness. (Casey, Alison)
Jun 13, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] : Motion Hearing continued to 6/13/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Jun 13, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 6/13/2018 re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibit C entered (Janssen's Opposition to Defendants' MSJ of Non-Infringement Based on Ensnarement - Supplemental Slides); and Exhibit D entered (Defendants' MSJ on Ensnarement - Rebuttal Presentation). Parties shall confer and report again concerning possible resolution by 6/20/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Casey, Quirk, Cohen, Harris, Hurst, McConnell, Krishnan, Sanford, Martin, Kelly) (Bono, Christine)
Jun 12, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 6/12/2018 re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibit 1 entered (Docket Entry No. 229); Exhibit 2 entered (Docket Entry No. 230); Exhibit A entered (Defendants' MSJ on Ensnarement); and Exhibit B entered (Janssen's Opposition to Defendants' MSJ of Non-Infringement Based on Ensnarement). Hearing continued to 6/13/2018 at 10:00 a.m. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Casey, Harris, Cohen, Hurst, McConnell, Krishnan, Sanford, Martin) (Bono, Christine)
Jun 11, 2018	364	Response (10) Docket Text: Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to [316] Notice of Supplemental Authorities, re: Ensnarement Summary Judgment. (Martin, Andrea) (Page 1 only of Main Document 364 replaced to reflect correct security level of document on 6/11/2018) (Bono, Christine).
Jun 5, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] : Motion Hearing set for 6/12/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Jun 5, 2018	346	Order (1) Docket Text: Judge Mark L. Wolf: "It is hereby ORDERED that a hearing on defendants' motion for summary judgment on the issue of ensnarement shall commence onJune 12, 2018, at 10:00 a.m., and continue on June 13, 2018, ifnecessary." ORDER entered. (Bono, Christine)
Jun 4, 2018	317	Motion for Leave to File Excess Pages (3) Docket Text: Assented to MOTION for Leave to File Excess Pages by Janssen Biotech, Inc..(Casey, Alison)
Jun 4, 2018	318	Main Document (9) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 4 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
Jun 4, 2018	318	Exhibit 1 (1)
Jun 4, 2018	318	Exhibit 2 (6)
Jun 4, 2018	318	Exhibit 3 (1)
Jun 4, 2018	319	Main Document (8) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Martin, Andrea)
Jun 4, 2018	319	Exhibit 1 (5)
Jun 4, 2018	319	Exhibit 2 (1)
Jun 4, 2018	319	Exhibit 3 (6)
Jun 4, 2018	319	Exhibit 4 (1)
Jun 4, 2018	320	Main Document (9) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 6 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
Jun 4, 2018	320	Exhibit 1 (1)
Jun 4, 2018	320	Exhibit 2 (8)
Jun 4, 2018	320	Exhibit 3 (1)
Jun 4, 2018	321	Main Document (8) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Martin, Andrea)
Jun 4, 2018	321	Exhibit 1 (11)
Jun 4, 2018	321	Exhibit 2 (12)
Jun 4, 2018	321	Exhibit 3 (1)
Jun 4, 2018	321	Exhibit 4 (1)
Jun 4, 2018	322	Main Document (20) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Martin, Andrea)
Jun 4, 2018	322	Exhibit 1 (1)
Jun 4, 2018	322	Exhibit 2 (1)
Jun 4, 2018	322	Exhibit 3 (1)
Jun 4, 2018	322	Exhibit 4 (1)
Jun 4, 2018	322	Exhibit 5 (6)
Jun 4, 2018	322	Exhibit 6 (4)
Jun 4, 2018	323	Reply to Response to Motion (14) Docket Text: REPLY to Response to [241] MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	324	Reply to Response to Motion (27) Docket Text: REPLY to Response to [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	325	Main Document (1) Docket Text: Statement of Material Facts L.R. 56.1 re [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives(Janssen's Reply to Defendants' Statement of Counter-Facts on the Issue of Non-Infringing Alternatives) filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1-6 (Filed Under Seal))(Casey, Alison)
Jun 4, 2018	325	Exhibit 1-6 (Filed Under Seal) (1)
Jun 4, 2018	326	Response to Motion (3) Docket Text: RESPONSE to Motion re [280] MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	327	Response to Motion (3) Docket Text: RESPONSE to Motion re [272] MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	328	Opposition to Motion (17) Docket Text: Opposition re [274] MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	329	Main Document (4) Docket Text: AFFIDAVIT of A. Robert Quirk in Opposition re [274] MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 7, # (3) Exhibit 11, # (4) Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison)
Jun 4, 2018	329	Exhibit 1 (7)
Jun 4, 2018	329	Exhibit 7 (3)
Jun 4, 2018	329	Exhibit 11 (2)
Jun 4, 2018	329	Exhibit 2-6 and 8-10 (Filed Under Seal) (1)
Jun 4, 2018	330	Main Document (21) Docket Text: Opposition re [278] MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation, [276] MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1-11 (Filed Under Seal))(Casey, Alison)
Jun 4, 2018	330	Exhibit 1-11 (Filed Under Seal) (1)
Jun 4, 2018	331	Main Document (12) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 12 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jun 4, 2018	331	Exhibit 1 (1)
Jun 4, 2018	331	Exhibit 2 (1)
Jun 4, 2018	332	Main Document (12) Docket Text: Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # (2) Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # (3) Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # (4) Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # (5) Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # (6) Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # (7) Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison)
Jun 4, 2018	332	Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions) (10)
Jun 4, 2018	332	Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability) (22)
Jun 4, 2018	332	Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages) (11)
Jun 4, 2018	332	Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions) (9)
Jun 4, 2018	332	Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions) (28)
Jun 4, 2018	332	Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions) (103)
Jun 4, 2018	332	Exhibit 7 (Defendants' Positions on and Objections to Janssen's Propos (70)
Jun 4, 2018	333	Main Document (16) Docket Text: REPLY to Response to [242] MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1)(Martin, Andrea)
Jun 4, 2018	333	Exhibit 1 (1)
Jun 4, 2018	334	Opposition to Motion (19) Docket Text: Opposition re [284] MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Casey, Alison)
Jun 4, 2018	335	Main Document (4) Docket Text: AFFIDAVIT of Hui Li in Opposition re [284] MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 4, # (2) Exhibit 12, # (3) Exhibit 1-3 and 5-11 (Filed Under Seal))(Casey, Alison)
Jun 4, 2018	335	Exhibit 4 (9)
Jun 4, 2018	335	Exhibit 12 (6)
Jun 4, 2018	335	Exhibit 1-3 and 5-11 (Filed Under Seal) (1)
Jun 4, 2018	336	Opposition to Motion (19) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 11 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Jun 4, 2018	337	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Janssen's June 4 Filings by Janssen Biotech, Inc..(Casey, Alison)
Jun 4, 2018	338	Main Document (27) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Martin, Andrea)
Jun 4, 2018	338	Exhibit 1 (1)
Jun 4, 2018	338	Exhibit 2 (1)
Jun 4, 2018	338	Exhibit 3 (1)
Jun 4, 2018	338	Exhibit 4 (1)
Jun 4, 2018	338	Exhibit 5 (11)
Jun 4, 2018	338	Exhibit 6 (1)
Jun 4, 2018	338	Exhibit 7 (15)
Jun 4, 2018	338	Exhibit 8 (1)
Jun 4, 2018	339	Main Document (12) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 13 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1)(Martin, Andrea)
Jun 4, 2018	339	Exhibit 1 (8)
Jun 4, 2018	340	Main Document (26) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 14 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jun 4, 2018	340	Exhibit 1 (1)
Jun 4, 2018	340	Exhibit 2 (5)
Jun 4, 2018	341	Main Document (15) Docket Text: Opposition re [265] MOTION in Limine Nos. 4-14Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33)(Martin, Andrea)
Jun 4, 2018	341	Exhibit 1 (1)
Jun 4, 2018	341	Exhibit 2 (1)
Jun 4, 2018	341	Exhibit 3 (1)
Jun 4, 2018	341	Exhibit 4 (1)
Jun 4, 2018	341	Exhibit 5 (4)
Jun 4, 2018	341	Exhibit 6 (1)
Jun 4, 2018	341	Exhibit 7 (1)
Jun 4, 2018	341	Exhibit 8 (3)
Jun 4, 2018	341	Exhibit 9 (4)
Jun 4, 2018	341	Exhibit 10 (1)
Jun 4, 2018	341	Exhibit 11 (1)
Jun 4, 2018	341	Exhibit 12 (1)
Jun 4, 2018	341	Exhibit 13 (1)
Jun 4, 2018	341	Exhibit 14 (1)
Jun 4, 2018	341	Exhibit 15 (1)
Jun 4, 2018	341	Exhibit 16 (10)
Jun 4, 2018	341	Exhibit 17 (38)
Jun 4, 2018	341	Exhibit 18 (4)
Jun 4, 2018	341	Exhibit 19 (5)
Jun 4, 2018	341	Exhibit 20 (4)
Jun 4, 2018	341	Exhibit 21 (1)
Jun 4, 2018	341	Exhibit 22 (1)
Jun 4, 2018	341	Exhibit 23 (1)
Jun 4, 2018	341	Exhibit 24 (1)
Jun 4, 2018	341	Exhibit 25 (1)
Jun 4, 2018	341	Exhibit 26 (223)
Jun 4, 2018	341	Exhibit 27 (109)
Jun 4, 2018	341	Exhibit 28 (143)
Jun 4, 2018	341	Exhibit 29 (1)
Jun 4, 2018	341	Exhibit 30 (1)
Jun 4, 2018	341	Exhibit 31 (1)
Jun 4, 2018	341	Exhibit 32 (1)
Jun 4, 2018	341	Exhibit 33 (1)
Jun 4, 2018	342	Main Document (27) Docket Text: REPLY to Response to [239] MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Appendix A, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Martin, Andrea)
Jun 4, 2018	342	Appendix A (2)
Jun 4, 2018	342	Exhibit 1 (11)
Jun 4, 2018	342	Exhibit 2 (1)
Jun 4, 2018	342	Exhibit 3 (1)
Jun 4, 2018	342	Exhibit 4 (1)
Jun 4, 2018	342	Exhibit 5 (1)
Jun 4, 2018	342	Exhibit 6 (1)
Jun 4, 2018	343	Reply to Response to Motion (21) Docket Text: REPLY to Response to [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Jun 4, 2018	344	Main Document (1) Docket Text: Counter Statement of Material Facts L.R. 56.1 re [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing AlternativesResponse to Counterstatement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jun 4, 2018	344	Exhibit 1 (1)
Jun 4, 2018	344	Exhibit 2 (1)
Jun 4, 2018	345	Motion to Seal (8) Docket Text: Assented to MOTION to Seal Re Dkt 318-322, 331, 333, 336, 338-343 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jun 1, 2018	316	Main Document (5) Docket Text: Notice of Supplemental Authorities re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18]Janssen's Notice of Supplemental Authority (Attachments: # (1) Exhibit A)(Casey, Alison)
Jun 1, 2018	316	Exhibit A (41)
May 30, 2018	314	Restricted (0) Docket Text: SEALED UNREDACTED DOCUMENT: RE. [306] by Celltrion Health Care. # (1) Exhibit 30, # (2) Exhibit 31, # (3) Exhibit 32, # (4) Exhibit 33, # (5) Exhibit 34, # (6) Exhibit 35) (Franklin, Yvonne).
May 30, 2018	314	Restricted (0)
May 30, 2018	314	Exhibit 31 (6)
May 30, 2018	314	Restricted (6)
May 30, 2018	314	Exhibit 33 (5)
May 30, 2018	314	Exhibit 34 (6)
May 30, 2018	314	Restricted (6)
May 29, 2018	N/A	Order on Motion to Seal (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [286] Motion to Seal; granting [294] Motion for Leave to File Excess Pages ; If counsel has not already done so, counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting [296] Motion to Seal; granting [299] Motion to Seal; granting [301] Motion to Seal; granting [305] Motion to Seal. (Bono, Christine)
May 29, 2018	306	Main Document (27) Docket Text: REPLY to Response to [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 30, # (2) Exhibit 31, # (3) Exhibit 32, # (4) Exhibit 33, # (5) Exhibit 34, # (6) Exhibit 35)(Martin, Andrea)
May 29, 2018	306	Exhibit 30 (1)
May 29, 2018	306	Exhibit 31 (1)
May 29, 2018	306	Exhibit 32 (26)
May 29, 2018	306	Exhibit 33 (1)
May 29, 2018	306	Exhibit 34 (1)
May 29, 2018	306	Exhibit 35 (1)
May 29, 2018	307	Statement of Material Facts L.R. 56.1 (30) Docket Text: Counter Statement of Material Facts L.R. 56.1 re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18]Response to Counterstatement of Facts [Dkt 260] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
May 29, 2018	308	Motion to Seal (4) Docket Text: Assented to MOTION to Seal re Reply and SOF for Ensnarement MSJ by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 25, 2018	294	Motion for Leave to File Excess Pages (3) Docket Text: Assented to MOTION for Leave to File Excess Pages by 2 pages, re: Opposition to Dkt 245 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 25, 2018	295	Main Document (21) Docket Text: Opposition re [239] MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A (Filed Under Seal))(Casey, Alison)
May 25, 2018	295	Exhibit A (Filed Under Seal) (1)
May 25, 2018	296	Motion to Seal (3) Docket Text: Assented to MOTION to Seal the Expert Report of Sean Nicholson, Ph.D. by Janssen Biotech, Inc..(Casey, Alison)
May 25, 2018	297	Opposition to Motion (25) Docket Text: Opposition re [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison)
May 25, 2018	298	Main Document (1) Docket Text: Counter Statement of Material Facts L.R. 56.1 re [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1-4 (Filed Under Seal))(Casey, Alison)
May 25, 2018	298	Exhibit 1-4 (Filed Under Seal) (1)
May 25, 2018	299	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Dkt. Nos. 297 and 298, Janssen's Opposition to Defendants' Motion for Partial Summary Judgment on the Issue of Non-Infringing Alternatives, Counter Statement of Material Facts and Exhibits 1-4 by Janssen Biotech, Inc..(Casey, Alison)
May 25, 2018	300	Main Document (18) Docket Text: Opposition re [242] MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A (Filed Under Seal), # (2) Exhibit B (Previously Filed Under Seal), # (3) Exhibit C (Previously Filed Under Seal), # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F (Filed Under Seal), # (7) Exhibit G (Filed Under Seal), # (8) Exhibit H (Filed Under Seal), # (9) Exhibit I (Filed Under Seal), # (10) Exhibit J (Filed Under Seal), # (11) Exhibit K (Filed Under Seal), # (12) Exhibit L (Filed Under Seal), # (13) Exhibit M (Filed Under Seal), # (14) Exhibit N (Filed Under Seal), # (15) Exhibit O (Filed Under Seal), # (16) Exhibit P (Filed Under Seal), # (17) Exhibit Q (Filed Under Seal))(Casey, Alison)
May 25, 2018	300	Exhibit A (Filed Under Seal) (1)
May 25, 2018	300	Exhibit B (Previously Filed Under Seal) (29)
May 25, 2018	300	Exhibit C (Previously Filed Under Seal) (1)
May 25, 2018	300	Exhibit D (5)
May 25, 2018	300	Exhibit E (6)
May 25, 2018	300	Exhibit F (Filed Under Seal) (1)
May 25, 2018	300	Exhibit G (Filed Under Seal) (1)
May 25, 2018	300	Exhibit H (Filed Under Seal) (1)
May 25, 2018	300	Exhibit I (Filed Under Seal) (1)
May 25, 2018	300	Exhibit J (Filed Under Seal) (1)
May 25, 2018	300	Exhibit K (Filed Under Seal) (1)
May 25, 2018	300	Exhibit L (Filed Under Seal) (1)
May 25, 2018	300	Exhibit M (Filed Under Seal) (1)
May 25, 2018	300	Exhibit N (Filed Under Seal) (1)
May 25, 2018	300	Exhibit O (Filed Under Seal) (1)
May 25, 2018	300	Exhibit P (Filed Under Seal) (1)
May 25, 2018	300	Exhibit Q (Filed Under Seal) (1)
May 25, 2018	301	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Dkt. No. 300, Janssen's Opposition to Defendants' Motion to Exclude Certain Opinions of Michael Butler and Richard Lit Regarding Damages and Infringement and Accompanying Exhibits by Janssen Biotech, Inc..(Casey, Alison)
May 25, 2018	302	Main Document (20) Docket Text: Opposition re [241] MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Martin, Andrea)
May 25, 2018	302	Exhibit A (1)
May 25, 2018	302	Exhibit B (1)
May 25, 2018	302	Exhibit C (33)
May 25, 2018	303	Main Document (29) Docket Text: Opposition re [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Martin, Andrea)
May 25, 2018	303	Exhibit 1 (1)
May 25, 2018	303	Exhibit 2 (1)
May 25, 2018	303	Exhibit 3 (8)
May 25, 2018	303	Exhibit 4 (1)
May 25, 2018	303	Exhibit 5 (1)
May 25, 2018	303	Exhibit 6 (1)
May 25, 2018	303	Exhibit 7 (1)
May 25, 2018	303	Exhibit 8 (1)
May 25, 2018	303	Exhibit 9 (1)
May 25, 2018	303	Exhibit 10 (1)
May 25, 2018	303	Exhibit 11 (1)
May 25, 2018	303	Exhibit 12 (1)
May 25, 2018	303	Exhibit 13 (1)
May 25, 2018	303	Exhibit 14 (1)
May 25, 2018	303	Exhibit 15 (1)
May 25, 2018	303	Exhibit 16 (1)
May 25, 2018	303	Exhibit 17 (1)
May 25, 2018	303	Exhibit 18 (4)
May 25, 2018	303	Exhibit 19 (1)
May 25, 2018	303	Exhibit 20 (1)
May 25, 2018	303	Exhibit 21 (1)
May 25, 2018	303	Exhibit 22 (1)
May 25, 2018	303	Exhibit 23 (1)
May 25, 2018	303	Exhibit 24 (1)
May 25, 2018	303	Exhibit 25 (1)
May 25, 2018	303	Exhibit 26 (1)
May 25, 2018	304	Statement of Material Facts L.R. 56.1 (1) Docket Text: Counter Statement of Material Facts L.R. 56.1 re [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives[Filed Under Seal] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
May 25, 2018	305	Motion to Seal (6) Docket Text: Assented to MOTION to Seal re: Dkt 302, 303 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 21, 2018	N/A	Order on Motion for Extension of Time (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWING [264] Motion for Extension of Time to May 21, 2018; ALLOWING [271] Motion to Seal; ALLOWING [282] Motion to Seal. (Franklin, Yvonne)
May 21, 2018	284	Motion in Limine (3) Docket Text: MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 21, 2018	285	Main Document (15) Docket Text: MEMORANDUM in Support re [284] MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1)(Martin, Andrea)
May 21, 2018	285	Exhibit 1 (2)
May 21, 2018	286	Motion to Seal (3) Docket Text: Assented to MOTION to Seal re: Dkt 284 Motion in Limine Memorandum by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	265	Main Document (4) Docket Text: MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20)(Casey, Alison)
May 18, 2018	265	Exhibit 1 (95)
May 18, 2018	265	Exhibit 2 (1)
May 18, 2018	265	Exhibit 3 (1)
May 18, 2018	265	Exhibit 4 (4)
May 18, 2018	265	Exhibit 5 (18)
May 18, 2018	265	Exhibit 6 (3)
May 18, 2018	265	Exhibit 7 (5)
May 18, 2018	265	Exhibit 8 (1)
May 18, 2018	265	Exhibit 9 (1)
May 18, 2018	265	Exhibit 10 (1)
May 18, 2018	265	Exhibit 11 (1)
May 18, 2018	265	Exhibit 12 (1)
May 18, 2018	265	Exhibit 13 (1)
May 18, 2018	265	Exhibit 14 (1)
May 18, 2018	265	Exhibit 15 (9)
May 18, 2018	265	Exhibit 16 (7)
May 18, 2018	265	Exhibit 17 (1)
May 18, 2018	265	Exhibit 18 (1)
May 18, 2018	265	Exhibit 19 (1)
May 18, 2018	265	Exhibit 20 (1)
May 18, 2018	266	Memorandum in Support of Motion (23) Docket Text: MEMORANDUM in Support re [265] MOTION in Limine Nos. 4-14Motions in Limine Nos. 4-7 Regarding Infringement filed by Janssen Biotech, Inc.. (Casey, Alison)
May 18, 2018	267	Memorandum in Support of Motion (19) Docket Text: MEMORANDUM in Support re [265] MOTION in Limine Nos. 4-14Motions in Limine Nos. 8-10 Regarding Economic Damages filed by Janssen Biotech, Inc.. (Casey, Alison)
May 18, 2018	268	Memorandum in Support of Motion (23) Docket Text: MEMORANDUM in Support re [265] MOTION in Limine Nos. 4-14Motions in Limine Nos. 11-12 Regarding Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison)
May 18, 2018	269	Memorandum in Support of Motion (18) Docket Text: MEMORANDUM in Support re [265] MOTION in Limine Nos. 4-14Motion in Limine No. 13 to Preclude Evidence or Argument that Janssen is Employing a Double Standard for Infringement and Validity filed by Janssen Biotech, Inc.. (Casey, Alison)
May 18, 2018	270	Memorandum in Support of Motion (19) Docket Text: MEMORANDUM in Support re [265] MOTION in Limine Nos. 4-14Motion in Limine No. 14 to Bifurcate Trial filed by Janssen Biotech, Inc.. (Casey, Alison)
May 18, 2018	271	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Exhibits 1-3, 8-14 and 17-20 to Janssen's Motion in Limine Nos. 4-14 (Dkt. No. 265) and Janssen's Motions in Limine Nos. 11-14 (Dkt. Nos. 268, 269 and 270) by Janssen Biotech, Inc..(Casey, Alison)
May 18, 2018	272	Motion in Limine (4) Docket Text: MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	273	Main Document (8) Docket Text: MEMORANDUM in Support re [272] MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
May 18, 2018	273	Exhibit 1 (1)
May 18, 2018	273	Exhibit 2 (1)
May 18, 2018	273	Exhibit 3 (1)
May 18, 2018	274	Motion in Limine (4) Docket Text: MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	275	Main Document (11) Docket Text: MEMORANDUM in Support re [274] MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Martin, Andrea)
May 18, 2018	275	Exhibit 1 (1)
May 18, 2018	275	Exhibit 2 (3)
May 18, 2018	275	Exhibit 3 (3)
May 18, 2018	275	Exhibit 4 (1)
May 18, 2018	275	Exhibit 5 (4)
May 18, 2018	276	Motion in Limine (4) Docket Text: MOTION in Limine to Preclude Evidence and Argument re: Speculation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	277	Main Document (8) Docket Text: MEMORANDUM in Support re [276] MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
May 18, 2018	277	Exhibit 1 (1)
May 18, 2018	277	Exhibit 2 (1)
May 18, 2018	277	Exhibit 3 (1)
May 18, 2018	278	Motion in Limine (4) Docket Text: MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	279	Main Document (9) Docket Text: MEMORANDUM in Support re [278] MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
May 18, 2018	279	Exhibit 1 (1)
May 18, 2018	279	Exhibit 2 (1)
May 18, 2018	279	Exhibit 3 (1)
May 18, 2018	280	Motion in Limine (4) Docket Text: MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 18, 2018	281	Main Document (13) Docket Text: MEMORANDUM in Support re [280] MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Martin, Andrea)
May 18, 2018	281	Exhibit 1 (1)
May 18, 2018	281	Exhibit 2 (1)
May 18, 2018	281	Exhibit 3 (1)
May 18, 2018	281	Exhibit 4 (1)
May 18, 2018	282	Motion to Seal (6) Docket Text: Assented to MOTION to Seal re: Memos and Exhibits re: Motions in Limine (Dkt 272-280) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 17, 2018	264	Motion for Extension of Time (3) Docket Text: Assented to MOTION for Extension of Time to 5/21/18 to File Motion in Limine re Discovery Corresp. by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 15, 2018	N/A	Order on Motion to Seal (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWED granting [243] Motion to Seal; granting [248] Motion to Seal; granting [249] Motion to Seal; granting [261] Motion to Seal. (Franklin, Yvonne)
May 10, 2018	259	Opposition to Motion (30) Docket Text: Opposition re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Casey, Alison)
May 10, 2018	260	Main Document (48) Docket Text: Counter Statement of Material Facts L.R. 56.1 re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 7, # (4) Exhibit 8, # (5) Exhibit 9, # (6) Exhibit 13, # (7) Exhibit 14, # (8) Exhibit 15, # (9) Exhibit 17, # (10) Exhibit 18, # (11) Exhibit 31, # (12) Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison)
May 10, 2018	260	Exhibit 1 (9)
May 10, 2018	260	Exhibit 2 (55)
May 10, 2018	260	Exhibit 7 (4)
May 10, 2018	260	Exhibit 8 (16)
May 10, 2018	260	Exhibit 9 (51)
May 10, 2018	260	Exhibit 13 (7)
May 10, 2018	260	Exhibit 14 (82)
May 10, 2018	260	Exhibit 15 (257)
May 10, 2018	260	Exhibit 17 (59)
May 10, 2018	260	Exhibit 18 (12)
May 10, 2018	260	Exhibit 31 (95)
May 10, 2018	260	Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal) (1)
May 10, 2018	261	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Janssens Memorandum of Law in Opposition to Motion for Summary Judgment for Non-Infringement Based on Ensnarement (Dkt. No. 259), Counter Statement of Material Facts L.R. 56.1 and Accompanying Exhibits (Dkt. No. 260) by Janssen Biotech, Inc..(Casey, Alison)
May 9, 2018	257	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Barbara L. Mullin Filing fee: $ 100, receipt number 0101-7131442 by Janssen Biotech, Inc.. (Attachments: # (1) Affidavit of Barbara L. Mullin)(Casey, Alison)
May 9, 2018	257	Affidavit of Barbara L. Mullin (1)
May 9, 2018	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [257] Motion for Leave to Appear Pro Hac Vice Added Barbara L. Mullin. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
May 7, 2018	255	Opposition to Motion (5) Docket Text: Opposition re [234] MOTION for Order to Begin Trial on August 6, 2018 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
May 7, 2018	256	Notice of Withdrawal of Appearance (3) Docket Text: NOTICE of Withdrawal of Appearance by John C. Adkisson for John C. Adkisson, Robert Oakes, John Kilyk, Jr., and Bruce M. Gagala (Adkisson, John)
May 4, 2018	236	Motion for Partial Summary Judgment (5) Docket Text: MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 4, 2018	237	Main Document (10) Docket Text: Statement of Material Facts L.R. 56.1 re [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
May 4, 2018	237	Exhibit 1 (1)
May 4, 2018	237	Exhibit 2 (1)
May 4, 2018	238	Memorandum in Support of Motion (16) Docket Text: MEMORANDUM in Support re [236] MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
May 4, 2018	239	Motion in Limine (4) Docket Text: MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 4, 2018	240	Main Document (28) Docket Text: MEMORANDUM in Support re [239] MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Martin, Andrea)
May 4, 2018	240	Exhibit 1 (1)
May 4, 2018	240	Exhibit 2 (1)
May 4, 2018	240	Exhibit 3 (1)
May 4, 2018	240	Exhibit 4 (5)
May 4, 2018	240	Exhibit 5 (1)
May 4, 2018	240	Exhibit 6 (1)
May 4, 2018	240	Exhibit 7 (1)
May 4, 2018	240	Exhibit 8 (1)
May 4, 2018	240	Exhibit 9 (1)
May 4, 2018	240	Exhibit 10 (1)
May 4, 2018	240	Exhibit 11 (1)
May 4, 2018	240	Exhibit 12 (8)
May 4, 2018	240	Exhibit 13 (1)
May 4, 2018	240	Exhibit 14 (1)
May 4, 2018	241	Main Document (15) Docket Text: MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A-F (Filed Under Seal))(Casey, Alison)
May 4, 2018	241	Exhibit A-F (Filed Under Seal) (1)
May 4, 2018	242	Motion in Limine (4) Docket Text: MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 4, 2018	243	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Exhibits A-F to Janssen's Motion to Exclude the Testimony of Rebecca Betensky, Ph.D. by Janssen Biotech, Inc..(Casey, Alison)
May 4, 2018	244	Main Document (18) Docket Text: MEMORANDUM in Support re [242] MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9)(Martin, Andrea)
May 4, 2018	244	Exhibit 1 (1)
May 4, 2018	244	Exhibit 2 (1)
May 4, 2018	244	Exhibit 3 (1)
May 4, 2018	244	Exhibit 4 (1)
May 4, 2018	244	Exhibit 5 (1)
May 4, 2018	244	Exhibit 6 (1)
May 4, 2018	244	Exhibit 7 (1)
May 4, 2018	244	Exhibit 8 (1)
May 4, 2018	244	Exhibit 9 (1)
May 4, 2018	245	Motion for Summary Judgment (3) Docket Text: MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives by Janssen Biotech, Inc..(Casey, Alison)
May 4, 2018	246	Memorandum in Support of Motion (26) Docket Text: MEMORANDUM in Support re [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison)
May 4, 2018	247	Main Document (1) Docket Text: Statement of Material Facts L.R. 56.1 re [245] MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives(Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1-29 and 32-54 (Filed Under Seal), # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 55, # (5) Exhibit 56)(Casey, Alison)
May 4, 2018	247	Exhibit 1-29 and 32-54 (Filed Under Seal) (1)
May 4, 2018	247	Exhibit 30 (7)
May 4, 2018	247	Exhibit 31 (139)
May 4, 2018	247	Exhibit 55 (5)
May 4, 2018	247	Exhibit 56 (3)
May 4, 2018	248	Motion to Seal (6) Docket Text: Assented to MOTION to Seal re: Dkt 236, 239, 242 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
May 4, 2018	249	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Memorandum of Law in Support of Janssen's Motion for Summary Judgment on the Issue of Non-Infringing Alternatives, Statement of Material Facts L.R. 56.1, and Exhibits 1-29 and 32-54 to the Statement of Material Facts by Janssen Biotech, Inc..(Casey, Alison)
Apr 23, 2018	233	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [231] Motion to Seal (Bono, Christine)
Apr 23, 2018	234	Main Document (5) Docket Text: MOTION for Order to Begin Trial on August 6, 2018 by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A)(Casey, Alison)
Apr 23, 2018	234	Exhibit A (5)
Apr 6, 2018	226	Motion for Summary Judgment (5) Docket Text: MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Apr 6, 2018	227	Main Document (39) Docket Text: MEMORANDUM in Support re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6 (Redacted), # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29)(Martin, Andrea) Modified on 4/6/2018 exhibit 6 replaced with redacted version per filer. (Franklin, Yvonne). (Attachment 6 replaced on 4/6/2018) (Franklin, Yvonne).
Apr 6, 2018	227	Exhibit 1 (5)
Apr 6, 2018	227	Exhibit 2 (5)
Apr 6, 2018	227	Exhibit 3 (15)
Apr 6, 2018	227	Exhibit 4 (1)
Apr 6, 2018	227	Exhibit 5 (123)
Apr 6, 2018	227	Exhibit 6 (8)
Apr 6, 2018	227	Exhibit 7 (23)
Apr 6, 2018	227	Exhibit 8 (7)
Apr 6, 2018	227	Exhibit 9 (3)
Apr 6, 2018	227	Exhibit 10 (17)
Apr 6, 2018	227	Exhibit 11 (8)
Apr 6, 2018	227	Exhibit 12 (15)
Apr 6, 2018	227	Exhibit 13 (12)
Apr 6, 2018	227	Exhibit 14 (7)
Apr 6, 2018	227	Exhibit 15 (8)
Apr 6, 2018	227	Exhibit 16 (27)
Apr 6, 2018	227	Exhibit 17 (59)
Apr 6, 2018	227	Exhibit 18 (51)
Apr 6, 2018	227	Exhibit 19 (5)
Apr 6, 2018	227	Exhibit 20 (1)
Apr 6, 2018	227	Exhibit 21 (8)
Apr 6, 2018	227	Exhibit 22 (5)
Apr 6, 2018	227	Exhibit 23 (4)
Apr 6, 2018	227	Exhibit 24 (5)
Apr 6, 2018	227	Exhibit 25 (1)
Apr 6, 2018	227	Exhibit 26 (5)
Apr 6, 2018	227	Exhibit 27 (8)
Apr 6, 2018	227	Exhibit 28 (6)
Apr 6, 2018	227	Exhibit 29 (9)
Apr 6, 2018	228	Statement of Material Facts L.R. 56.1 (21) Docket Text: Statement of Material Facts L.R. 56.1 re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Apr 6, 2018	229	Addendum to Motion/Memorandum (3) Docket Text: ADDENDUM re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18]APPENDIX A to Memorandum and Statement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Apr 6, 2018	230	Addendum to Motion/Memorandum (4) Docket Text: ADDENDUM re [226] MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18]APPENDIX B to Memorandum and Statement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Apr 6, 2018	231	Motion to Seal (4) Docket Text: Assented to MOTION to Seal re: Ensnarement Summary Judgment Facts and Exhibits by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Apr 4, 2018	224	Order on Motion for Leave to File (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered ALLOWED [222] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. As plaintiff does not oppose the filing of a motion for summary judgment or the briefing schedule, this Motion is hereby ALLOWED and the proposed briefing schedule is ADOPTED. (Franklin, Yvonne)
Apr 4, 2018	225	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered ALLOWED [223] Motion to Seal. (Franklin, Yvonne)
Apr 3, 2018	221	Main Document (2) Docket Text: REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # (1) Opening Infringement Expert Report of Professor Florian M. Wurm, # (2) Lab Report of Professor Florian M. Wurm, # (3) Opening Infringement Expert Report of Professor Michael Butler, # (4) Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # (5) Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # (6) Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison)
Apr 3, 2018	221	Opening Infringement Expert Report of Professor Florian M. Wurm (36)
Apr 3, 2018	221	Lab Report of Professor Florian M. Wurm (63)
Apr 3, 2018	221	Opening Infringement Expert Report of Professor Michael Butler (54)
Apr 3, 2018	221	Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity (256)
Apr 3, 2018	221	Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement (94)
Apr 3, 2018	221	Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement (81)
Apr 3, 2018	222	Main Document (8) Docket Text: MOTION for Leave to File Ensnarement Summary Judgment, for 30 page brief, hearing and to set briefing schedule [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Apr 3, 2018	222	Exhibit 1 (5)
Apr 3, 2018	222	Exhibit 2 (45)
Apr 3, 2018	223	Motion to Seal (4) Docket Text: MOTION to Seal re: Ensnarement Summary Judgment Memorandum by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Apr 2, 2018	N/A	Order on Motion for Modification (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered finding as moot [137] Motion for Modification; withdrawing [192] Motion to Compel, per [214]. (Bono, Christine)
Mar 30, 2018	219	Transcript (30) Docket Text: Transcript of Telephone Conference held on March 26, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 4/20/2018. Redacted Transcript Deadline set for 4/30/2018. Release of Transcript Restriction set for 6/28/2018. (Scalfani, Deborah)
Mar 30, 2018	N/A	Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah)
Mar 26, 2018	216	Order (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered. re [215] Stipulation filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine)
Mar 26, 2018	N/A	Telephone Conference (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Telephone Conference held on 3/26/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Repicky, Cutri, Sanford, Martin) (Bono, Christine)
Mar 26, 2018	218	Order (1) Docket Text: Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' request to compel plaintiff to produce "emails and email attachments related to Janssen's communications with its customers about Remicade pricing, discounts, rebates, and reimbursement" in addition to the documents plaintiff has agreed to produce, Docket No. 202 at 1, is DENIED. 2. The parties shall, by April 4, 2018, file redacted copies of the expert reports of Drs. Florian Wurm, Michael Butler, and Michael Glacken for the public record." ORDER entered. re [202] Status Report filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine)
Mar 22, 2018	215	Stipulation (3) Docket Text: STIPULATION re [210] Order on Motion for Extension of Time Re: Expert Report of Dr. Leonard to March 29, 2018 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Mar 20, 2018	212	Motion to Withdraw (3) Docket Text: Assented to MOTION to Withdraw [192] MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents by Janssen Biotech, Inc..(Casey, Alison)
Mar 20, 2018	213	Order (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered. re [211] Stipulation filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine)
Mar 20, 2018	214	Order on Motion to Withdraw (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting [212] Motion to Withdraw (Bono, Christine)
Mar 16, 2018	211	Stipulation (4) Docket Text: STIPULATION Joint Stipulation Regarding Expert Reports by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Mar 15, 2018	N/A	Notice of Hearing (0) Docket Text: ELECTRONIC NOTICE of Hearing. Telephone Conference set for 3/26/2018 02:15 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to participants separately by the Deputy Clerk. (Bono, Christine)
Mar 15, 2018	N/A	Order on Motion for Extension of Time (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [208] Motion for Extension of Time (Bono, Christine)
Mar 13, 2018	208	Motion for Extension of Time (3) Docket Text: MOTION for Extension of Time to March 23, 2018 to File Expert Report [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Mar 12, 2018	205	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting [195] Motion to Seal (Bono, Christine)
Mar 12, 2018	206	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting [197] Motion to Seal (Bono, Christine)
Mar 12, 2018	207	Order on Motion for Extension of Time (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting [201] Motion for Extension of Time (Bono, Christine)
Mar 9, 2018	204	Main Document (10) Docket Text: Response by Janssen Biotech, Inc. to [202] Status Report . (Attachments: # (1) Exhibit 1)(Casey, Alison)
Mar 9, 2018	204	Exhibit 1 (2)
Mar 8, 2018	N/A	Notice of correction to docket made by Court staff (0) Docket Text: Notice of correction to docket made by Court staff. Correction: D.E. 132 and 195 corrected because: #[132] replaced with corrected version. #[195] replaced with corrected version, both provided by filer. (Franklin, Yvonne)
Mar 7, 2018	201	Motion for Extension of Time (3) Docket Text: MOTION for Extension of Time to 3/21/18 to Oppose Motion to Compel [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Mar 7, 2018	202	Main Document (8) Docket Text: STATUS REPORT And Request to Reschedule Discovery Dispute Call by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Martin, Andrea)
Mar 7, 2018	202	Exhibit 1 (27)
Mar 7, 2018	202	Exhibit 2 (4)
Mar 7, 2018	202	Exhibit 3 (11)
Mar 2, 2018	196	Answer to Counterclaim (21) Docket Text: ANSWER to Counterclaim Defendants' Answer to Plaintiff's Counterclaims under 35 USC 271(f)(1) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Mar 2, 2018	197	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Defendants Answer to Janssen Counterclaim by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Feb 28, 2018	191	Order (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ELECTRONIC ORDER entered. re [190] Status Report filed by Janssen Biotech, Inc. (Bono, Christine) (Bono, Christine).
Feb 28, 2018	192	Motion to Compel (3) Docket Text: MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents by Janssen Biotech, Inc..(Casey, Alison)
Feb 28, 2018	193	Memorandum in Support of Motion (18) Docket Text: MEMORANDUM in Support re [192] MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents(Redacted) filed by Janssen Biotech, Inc.. (Casey, Alison)
Feb 28, 2018	194	Main Document (7) Docket Text: AFFIDAVIT in Support re [192] MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents. (Attachments: # (1) Exhibit A (Filed Under Seal), # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F (Filed Under Seal), # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L-P (Filed Under Seal))(Casey, Alison)
Feb 28, 2018	194	Exhibit A (Filed Under Seal) (1)
Feb 28, 2018	194	Exhibit B (2)
Feb 28, 2018	194	Exhibit C (2)
Feb 28, 2018	194	Exhibit D (1)
Feb 28, 2018	194	Exhibit E (1)
Feb 28, 2018	194	Exhibit F (Filed Under Seal) (1)
Feb 28, 2018	194	Exhibit G (3)
Feb 28, 2018	194	Exhibit H (13)
Feb 28, 2018	194	Exhibit I (4)
Feb 28, 2018	194	Exhibit J (4)
Feb 28, 2018	194	Exhibit K (16)
Feb 28, 2018	194	Exhibit L-P (Filed Under Seal) (1)
Feb 28, 2018	195	Motion to Seal (3) Docket Text: MOTION to Seal Janssen's Memorandum in Support of its Motion to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents and Certain Memorandum Exhibits by Janssen Biotech, Inc..(Casey, Alison) (Main Document 195 replaced on 3/8/2018) (Franklin, Yvonne). Modified on 3/8/2018 with corrected version provided by filer. (Franklin, Yvonne).
Feb 27, 2018	190	Status Report (4) Docket Text: STATUS REPORT JOINT REPORT REGARDING FACT WITNESS DEPOSITIONS by Janssen Biotech, Inc.. (Casey, Alison)
Feb 23, 2018	187	Transcript (138) Docket Text: Transcript of Motion Hearing held on February 16, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com Redaction Request due 3/16/2018. Redacted Transcript Deadline set for 3/26/2018. Release of Transcript Restriction set for 5/24/2018. (Scalfani, Deborah) (Main Document 187 replaced on 2/23/2018) (Scalfani, Deborah).
Feb 23, 2018	N/A	Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah)
Feb 23, 2018	189	Notice of Withdrawal of Appearance (2) Docket Text: NOTICE of Withdrawal of Appearance by Andrea L. Martin Notice of Withdrawal of Saunak Desai from Representing Defendants (Martin, Andrea)
Feb 22, 2018	186	Order (1) Docket Text: Judge Mark L. Wolf: "The hearing tentatively scheduled for February 23, 2018 is hereby CANCELLED." ENDORSED ORDER entered. re [185] Status Report filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine)
Feb 21, 2018	185	Status Report (4) Docket Text: STATUS REPORT JOINT REPORT REGARDING DISCOVERY DISPUTES by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Feb 20, 2018	177	Transcript (236) Docket Text: Transcript of Hearing held on January 30, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah)
Feb 20, 2018	178	Transcript (141) Docket Text: Transcript of Hearing held on January 31, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah)
Feb 20, 2018	179	Transcript (117) Docket Text: Transcript of Hearing held on February 1, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah)
Feb 20, 2018	180	Transcript (36) Docket Text: Transcript of Hearing held on February 2, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah)
Feb 20, 2018	N/A	Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah)
Feb 20, 2018	182	Order on Motion to Compel (2) Docket Text: Judge Mark L. Wolf: ORDER entered denying [86] Motion to Compel; denying [127] Motion to Compel. (Bono, Christine)
Feb 20, 2018	183	Memorandum & ORDER (4) Docket Text: Judge Mark L. Wolf: "...[I]t is hereby ORDERED that the Motion to Dismiss orStrike Janssen's Counterclaims under 35 U.S.C. §271(f) (Docket No.122) is DENIED." ORDER entered. MEMORANDUM AND ORDER. (Bono, Christine)
Feb 16, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 2/16/2018. Exhibits 1-3 entered. (Court Reporter: Debra Joyce at joycedebra@gmail.com.)(Attorneys present: Diskant, Casey, Jackson, Quirk, Hales, Cutri, Klein, Martin, Kelly, Shmuel, Adkisson, Gagala, Haug, Barlow, Kuzmich) (Bono, Christine)
Feb 15, 2018	176	Scheduling Order (2) Docket Text: Judge Mark L. Wolf: ORDER entered. SCHEDULING ORDER. (Bono, Christine)
Feb 13, 2018	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [174] Motion for Leave to Appear Pro Hac Vice Added Sandra Kuzmich, Edgar H. Haug. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Feb 12, 2018	174	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Edgar Haug and Sandra Kuzmich Filing fee: $ 200, receipt number 0101-7006052 by Biogen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Barlow, Joshua)
Feb 12, 2018	174	Exhibit A (3)
Feb 12, 2018	174	Exhibit B (3)
Feb 9, 2018	169	Sur-Reply to Motion (19) Docket Text: SUR-REPLY to Motion re [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f)(Redacted Version - Leave to File Granted 1/30/18) filed by Janssen Biotech, Inc.. (Casey, Alison)
Feb 9, 2018	N/A	Order on Motion to Seal (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [54] Motion to Seal; granting [80] Motion for Extension of Time; granting [88] Motion to Seal; granting [140] Motion to Seal; granting [156] Motion for Leave to File Document ; If counsel has not already done so, counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting [157] Motion to Seal (Bono, Christine)
Feb 9, 2018	171	Main Document (7) Docket Text: RESPONSE TO COURT ORDER by Janssen Biotech, Inc. (Joint Submission regarding Janssen's motion to limit the testimony of Michael Glacken Sc. D. with respect to infringement). (Attachments: # (1) Exhibit A (Janssen's Submission - Filed Under Seal), # (2) Exhibit B (Defendants' Submission - Filed Under Seal))(Casey, Alison)
Feb 9, 2018	171	Exhibit A (Janssen's Submission - Filed Under Seal) (1)
Feb 9, 2018	171	Exhibit B (Defendants' Submission - Filed Under Seal) (1)
Feb 9, 2018	172	Main Document (2) Docket Text: Proposed Document(s) submitted by Janssen Biotech, Inc.. Document received: Proposed Scheduling Order. (Attachments: # (1) Exhibit A (Proposed Scheduling Order))(Casey, Alison)
Feb 9, 2018	172	Exhibit A (Proposed Scheduling Order) (3)
Feb 8, 2018	167	Order (1) Docket Text: Judge Mark L. Wolf: "It is hereby ORDERED that: 1. A hearing on the motions to compel Janssen Biotech, Inc. ("Janssen") and Biogen, Inc. ("Biogen") to produce documents and a Biogen witness concerning the media used to produce Renflexis (Docket Nos. 86 and 127) shall be held on February 16, 2018, at 10:00 a.m. 2. The parties shall also be prepared to argue the defendants' motion to strike or dismiss Janssen's counterclaims in reply under 35 U.S.C. §271(f) (Docket No. 122)." ORDER entered. (Bono, Christine)
Feb 8, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS, [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS, [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) : Motion Hearing set for 2/16/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Feb 2, 2018	164	Recommendations for Scheduling Order (11) Docket Text: Recommendations for Scheduling Order Defendants Proposed Modified Schedule. (Martin, Andrea)
Feb 2, 2018	165	Recommendations for Scheduling Order (7) Docket Text: Recommendations for Scheduling Order Janssen's Position on Case Schedule. (Casey, Alison)
Feb 2, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Hearing concluded on 2/2/2018. Parties are ordered to reserve 6/11/2018-6/29/2018 for pending motions and 7/30/2018-10/1/2018 for trial. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Davies, Casey, Harris, Hurst, Hales, Sanford, Cutri, Martin, Meyers) (Bono, Christine)
Feb 1, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Resetting Hearing on Motion * TIME CHANGE ONLY * Motion Hearing set for 2/1/2018 11:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Feb 1, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 2/1/2018. Exhibits 13-14 entered. Hearing shall resume at 10:00 a.m. on 2/2/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Cohen, Casey, Harris, Hurst, Hales, Desai, Sanford, Cutri, Klein, Kelly, Martin, Meyers) (Bono, Christine)
Feb 1, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Motion Hearing. Motion Hearing to resume 2/2/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Jan 31, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 1/31/2018. Exhibits 9-12 entered. Hearing shall resume at 11:00 a.m. on 2/1/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Davies, Casey, Harris, Hurst, Hales, Desai, Sanford, McConnell, Cutri, Klein, Kelly, Martin, Meyers) (Bono, Christine)
Jan 30, 2018	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 1/30/2018. Plaintiff calls Dr. Michael Butler and Dr. Florian Wurm for testimony. Exhibits 1-8 entered. Hearing shall resume at 10:00 a.m. on 1/31/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Cohen, Fischer, Casey, Harris, Hurst, Hales, Sanford, McConnell, Klein, Kelly, Desai, Meyers, Martin) (Bono, Christine)
Jan 26, 2018	151	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting [124] Motion to Seal. (Franklin, Yvonne)
Jan 26, 2018	152	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting [133] Motion to Seal. (Franklin, Yvonne)
Jan 26, 2018	153	Order on Motion to Seal Document (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting [144] Motion to Seal Document. (Franklin, Yvonne)
Jan 26, 2018	154	Order on Motion for Leave to File (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting [145] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Franklin, Yvonne)
Jan 26, 2018	155	Main Document (23) Docket Text: REPLY to Response to [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f)[Leave to File Granted 1/26/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19)(Martin, Andrea)
Jan 26, 2018	155	Exhibit 18 (4)
Jan 26, 2018	155	Exhibit 19 (2)
Jan 26, 2018	156	Main Document (3) Docket Text: Assented to MOTION for Leave to File Janssen's Surreply in Opposition to Defendants' Motion to Strike or Dismiss Janssen's Counterclaims Under 35 U.S.C. s. 271(f)(1) by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A (Janssen's Surreply))(Casey, Alison)
Jan 26, 2018	156	Exhibit A (Janssen's Surreply) (20)
Jan 26, 2018	157	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Janssen's Surreply in Opposition to Defendants' Motion to Strike or Dismiss Janssen's Counterclaims Under 35 U.S.C. s. 271(f)(1) by Janssen Biotech, Inc..(Casey, Alison)
Jan 25, 2018	149	Order (3) Docket Text: Judge Mark L. Wolf: ORDER entered, re [147] Status Report. See attached Order. (Bono, Christine)
Jan 25, 2018	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Resetting (* AS TO TIME ONLY *) Hearing on Motions: Motion Hearing set for 1/30/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 1/31/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/1/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/2/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Jan 24, 2018	148	Letter/request (non-motion) (2) Docket Text: Letter/request (non-motion) from Counsel for Biogen RE: Hearing Date on Defendants Motion to Compel Biogens Compliance with Subpoenas (Dkt. No. 127) . (Barlow, Joshua)
Jan 22, 2018	147	Status Report (12) Docket Text: STATUS REPORT Joint Report re: Outline for Daubert Hearings scheduled for 1/30/18 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Jan 19, 2018	145	Main Document (3) Docket Text: MOTION for Leave to File [Unopposed] Leave to File Reply In Support of Motion to Dismiss Counterclaims by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit A [Proposed Reply])(Martin, Andrea)
Jan 19, 2018	145	Exhibit A [Proposed Reply] (30)
Jan 18, 2018	143	Main Document (12) Docket Text: RESPONSE to Motion re [137] MOTION to Modify Case Schedule filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A (Filed Under Seal), # (2) Exhibit B, # (3) Exhibit C)(Casey, Alison)
Jan 18, 2018	143	Exhibit A (Filed Under Seal) (1)
Jan 18, 2018	143	Exhibit B (3)
Jan 18, 2018	143	Exhibit C (3)
Jan 18, 2018	144	Motion to Seal Document (3) Docket Text: Assented to MOTION to Seal Document [143] Response to Motion (Exhibit A to Janssen's Response to Defendants' Motion to Modify Case Schedule) by Janssen Biotech, Inc..(Casey, Alison)
Jan 16, 2018	N/A	Notice of correction to docket made by Court staff (0) Docket Text: Notice of correction to docket made by Court staff. Correction: D.E. 135 corrected because: Motion terminated as main document attached by filer in error. (Franklin, Yvonne)
Jan 16, 2018	N/A	Order on Motion for Miscellaneous Relief (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [136] Motion for Relief from Order to Appear. (Bono, Christine)
Jan 16, 2018	140	Motion to Seal (5) Docket Text: Assented to MOTION to Seal [Previously filed as Dkt 124, refiled to reflect Plaintiff assent] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jan 16, 2018	141	Opposition to Motion (21) Docket Text: Opposition re [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Biogen, Inc.. (Barlow, Joshua)
Jan 16, 2018	142	Affidavit in Opposition to Motion (6) Docket Text: AFFIDAVIT of John Ruesch in Opposition re [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Biogen, Inc.. (Barlow, Joshua)
Jan 15, 2018	137	Main Document (12) Docket Text: MOTION to Modify Case Schedule by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Appendix A, # (2) Exhibit 1, # (3) Exhibit 2)(Martin, Andrea)
Jan 15, 2018	137	Appendix A (1)
Jan 15, 2018	137	Exhibit 1 (10)
Jan 15, 2018	137	Exhibit 2 (4)
Jan 12, 2018	135	Main Document (4) Docket Text: MOTION Order to Appear Relief from Order to Appear by Celltrion Healthcare Co., Ltd.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jan 12, 2018	135	Exhibit 1 (4)
Jan 12, 2018	135	Exhibit 2 (2)
Jan 12, 2018	136	Main Document (6) Docket Text: MOTION Relief from Order to Appear CORRECTED from Dkt 135 [Relief Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Martin, Andrea)
Jan 12, 2018	136	Exhibit 1 (12)
Jan 12, 2018	136	Exhibit 2 (2)
Jan 11, 2018	132	Main Document (28) Docket Text: Opposition re [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne).
Jan 11, 2018	132	Exhibit A (6)
Jan 11, 2018	132	Exhibit B (7)
Jan 11, 2018	132	Exhibit C (6)
Jan 11, 2018	132	Exhibit D (38)
Jan 11, 2018	132	Exhibit E (5)
Jan 11, 2018	132	Exhibit F (Filed Under Seal) (1)
Jan 11, 2018	133	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Opposition re [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) by Janssen Biotech, Inc..(Casey, Alison)
Jan 8, 2018	131	Order on Motion for Extension of Time to File Response/Reply (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered and (ALLOWED) granting [129] Motion for Extension of Time to File Response re [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS Responses due by 1/16/2018 (Franklin, Yvonne)
Jan 5, 2018	130	Sur-Reply to Motion (14) Docket Text: SUR-REPLY to Motion re [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (shmuel, Jenny)
Jan 4, 2018	129	Motion for Extension of Time to File Response/Reply (3) Docket Text: MOTION for Extension of Time to 1/16/18 to File Response/Reply as to [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS[UNOPPOSED] by Biogen, Inc..(Barlow, Joshua)
Dec 29, 2017	126	Reply to Response to Motion (11) Docket Text: REPLY to Response to [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS[Leave to File Granted 12/27/17] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc., Janssen Biotech, Inc.. (Martin, Andrea)
Dec 29, 2017	127	Motion to Compel (5) Docket Text: MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Dec 29, 2017	128	Main Document (15) Docket Text: MEMORANDUM in Support re [127] MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9)(Martin, Andrea)
Dec 29, 2017	128	Exhibit 1 (14)
Dec 29, 2017	128	Exhibit 2 (11)
Dec 29, 2017	128	Exhibit 3 (2)
Dec 29, 2017	128	Exhibit 4 (18)
Dec 29, 2017	128	Exhibit 5 (3)
Dec 29, 2017	128	Exhibit 6 (7)
Dec 29, 2017	128	Exhibit 7 (4)
Dec 29, 2017	128	Exhibit 8 (2)
Dec 29, 2017	128	Exhibit 9 (2)
Dec 28, 2017	N/A	Notice requesting courtesy copy (0) Docket Text: ELECTRONIC NOTICE issued requesting courtesy copy for [119] Memorandum in Opposition to Motion. Counsel who filed this document are requested to submit a courtesy copy of this document separating the exhibits. Also include a CD (with each exhibit as a separate attachment) and submit to the Clerk's Office by January 4, 2018. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Franklin, Yvonne)
Dec 28, 2017	N/A	Notice of correction to docket made by Court staff (0) Docket Text: Notice of correction to docket made by Court staff. Correction: D.E. 119, Exhibit 1 corrected because: entire exhibit filed as one document. All exhibits should have been separated and has been corrected with CD provided by filer. In the future filer should separate and file exhibits as separate attachments. Counsel is reminded to review the local rules and the attorney handbook when filing documents with the Court by accessing our web page, at www.mad.uscourts.gov under CM/ECF E-Filing. Yvonne Franklin, Docket Clerk (Franklin, Yvonne)
Dec 28, 2017	122	Motion to Dismiss (4) Docket Text: MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Dec 28, 2017	123	Main Document (28) Docket Text: MEMORANDUM in Support re [122] MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Martin, Andrea)
Dec 28, 2017	123	Exhibit 1 (3)
Dec 28, 2017	123	Exhibit 2 (70)
Dec 28, 2017	123	Exhibit 3 (19)
Dec 28, 2017	123	Exhibit 4 (1)
Dec 28, 2017	123	Exhibit 5 (1)
Dec 28, 2017	123	Exhibit 6 (1)
Dec 28, 2017	123	Exhibit 7 (1)
Dec 28, 2017	123	Exhibit 8 (1)
Dec 28, 2017	123	Exhibit 9 (1)
Dec 28, 2017	123	Exhibit 10 (1)
Dec 28, 2017	123	Exhibit 11 (1)
Dec 28, 2017	123	Exhibit 12 (1)
Dec 28, 2017	123	Exhibit 13 (1)
Dec 28, 2017	123	Exhibit 14 (1)
Dec 28, 2017	123	Exhibit 15 (1)
Dec 28, 2017	123	Exhibit 16 (35)
Dec 28, 2017	123	Exhibit 17 (1)
Dec 28, 2017	124	Motion to Seal (5) Docket Text: MOTION to Seal re Motion to Dismiss Dkt 123 et seq by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Dec 27, 2017	116	Order on Motion to Intervene (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered (ALLOWED)granting [103] Motion to Intervene. (Franklin, Yvonne)
Dec 27, 2017	117	Order on Motion for Leave to File (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered (ALLOWED) granting [113] Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Franklin, Yvonne)
Dec 27, 2017	118	Order (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER SCHEDULING FOR BRIEFING entered and (ALLOWED) granting [113]. (Franklin, Yvonne)
Dec 27, 2017	119	Main Document (17) Docket Text: MEMORANDUM in Opposition re [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit A, # (9) Exhibit B, # (10) Exhibit C, # (11) Exhibit D, # (12) Exhibit E, # (13) Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne).
Dec 27, 2017	119	Affidavit (2)
Dec 27, 2017	119	Exhibit 1 (25)
Dec 27, 2017	119	Exhibit 2 (22)
Dec 27, 2017	119	Exhibit 3 (4)
Dec 27, 2017	119	Exhibit 4 (3)
Dec 27, 2017	119	Exhibit 5 (3)
Dec 27, 2017	119	Exhibit 6 (2)
Dec 27, 2017	119	Exhibit A (12)
Dec 27, 2017	119	Exhibit B (14)
Dec 27, 2017	119	Exhibit C (7)
Dec 27, 2017	119	Exhibit D (4)
Dec 27, 2017	119	Exhibit E (3)
Dec 27, 2017	119	Exhibit F (3)
Dec 21, 2017	113	Main Document (5) Docket Text: Joint MOTION for Leave to File Reply and Sur-Reply Briefs and Proposed Schedules re Motion to Compel Third Party Documents by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Text of Proposed Order)(Martin, Andrea)
Dec 21, 2017	113	Text of Proposed Order (1)
Dec 21, 2017	114	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Saunek Desei and Noah Frank Filing fee: $ 200, receipt number 0101-6938525 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Affidavit Certificate of Saunak Desei, # (2) Affidavit Certificate of Noah Frank)(Martin, Andrea)
Dec 21, 2017	114	Affidavit Certificate of Saunak Desei (2)
Dec 21, 2017	114	Affidavit Certificate of Noah Frank (2)
Dec 21, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [114] Motion for Leave to Appear Pro Hac Vice Added Saunak Desai, Noah Frank. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 20, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [104] Motion for Leave to Appear Pro Hac Vice Added Robert M. Oakes. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 20, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [105] Motion for Leave to Appear Pro Hac Vice Added John C. Adkisson. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 20, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [106] Motion for Leave to Appear Pro Hac Vice Added Bruce M. Gagala. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 20, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [107] Motion for Leave to Appear Pro Hac Vice Added John Kilyk, Jr.. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 19, 2017	103	Main Document (3) Docket Text: MOTION to Intervene by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Exhibit A)(shmuel, Jenny)
Dec 19, 2017	103	Exhibit A (122)
Dec 19, 2017	104	Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for admission of Robert Oakes Filing fee: $ 100, receipt number 0101-6934793 by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Affidavit)(shmuel, Jenny)
Dec 19, 2017	104	Affidavit (3)
Dec 19, 2017	105	Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for admission of John C. Adkisson Filing fee: $ 100, receipt number 0101-6934873 by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Affidavit)(shmuel, Jenny)
Dec 19, 2017	105	Affidavit (3)
Dec 19, 2017	106	Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for admission of Bruce M. Gagala Filing fee: $ 100, receipt number 0101-6934883 by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Affidavit)(shmuel, Jenny)
Dec 19, 2017	106	Affidavit (3)
Dec 19, 2017	107	Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for admission of John Kilyk, Jr. Filing fee: $ 100, receipt number 0101-6934891 by Samsung Bioepis, Co., Ltd.. (Attachments: # (1) Affidavit)(shmuel, Jenny)
Dec 19, 2017	107	Affidavit (3)
Dec 19, 2017	108	Response to Motion (4) Docket Text: RESPONSE to Motion re [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Janssen Biotech, Inc.. (Casey, Alison)
Dec 13, 2017	102	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER (ALLOWED) entered granting [95] Motion to Seal. (Franklin, Yvonne)
Dec 12, 2017	101	Order (1) Docket Text: Judge Mark L. Wolf: "The jointly proposed schedule concerning discovery deadlines is hereby ADOPTED. The parties shall, by January 22, 2018, confer and propose a format for the Daubert hearings." ENDORSED ORDER entered. re [96] Status Report filed by Janssen Biotech, Inc. (Bono, Christine)
Dec 8, 2017	97	Transcript (47) Docket Text: Transcript of Teleconference held on December 5, 2017, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 12/29/2017. Redacted Transcript Deadline set for 1/8/2018. Release of Transcript Restriction set for 3/8/2018. (Scalfani, Deborah)
Dec 8, 2017	N/A	Notice of Filing of Official Transcript (0) Docket Text: NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah)
Dec 8, 2017	N/A	Notice of Hearing on Motion (0) Docket Text: ELECTRONIC NOTICE Setting Hearing on Motion Motion Hearing set for 1/30/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 1/31/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/1/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/2/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Dec 7, 2017	94	Answer to Counterclaim (13) Docket Text:Plaintiff's ANSWER to Counterclaim and, COUNTERCLAIM for Patent Infringement against All Defendants by Janssen Biotech, Inc..(Casey, Alison)
Dec 7, 2017	95	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Plaintiff's Answer to Counterclaim and Counterclaim for Patent Infringement against All Defendants (Dkt. No. 94) by Janssen Biotech, Inc..(Casey, Alison)
Dec 7, 2017	96	Status Report (4) Docket Text: STATUS REPORT Joint Submission Reporting Discovery Deadlines by Janssen Biotech, Inc.. (Casey, Alison)
Dec 6, 2017	93	Order (2) Docket Text: Judge Mark L. Wolf: ORDER entered. (Bono, Christine)
Dec 5, 2017	86	Motion to Compel (4) Docket Text: MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Dec 5, 2017	87	Main Document (11) Docket Text: MEMORANDUM in Support re [86] MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1 (includes Exhibits A-E), # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne).
Dec 5, 2017	87	Exhibit 1 (68)
Dec 5, 2017	87	Exhibit 2 (22)
Dec 5, 2017	87	Exhibit 3 (4)
Dec 5, 2017	87	Exhibit 4 (1)
Dec 5, 2017	87	Exhibit 5 (15)
Dec 5, 2017	87	Exhibit 6 (1)
Dec 5, 2017	88	Main Document (3) Docket Text: MOTION to Seal re Motion to Compel [Dkt 86,87] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Additional attachment(s) added on 12/5/2017: # (1) Exhibit 4, # (2) Exhibit 6) # (3) Cover Letter) (Franklin, Yvonne).
Dec 5, 2017	88	Restricted (3)
Dec 5, 2017	88	Restricted (3)
Dec 5, 2017	88	Restricted (3)
Dec 5, 2017	89	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Benjamin F. Jackson Filing fee: $ 100, receipt number 0101-6914577 by Janssen Biotech, Inc.. (Attachments: # (1) Certificate of Benjamin F. Jackson)(Casey, Alison)
Dec 5, 2017	89	Certificate of Benjamin F. Jackson (1)
Dec 5, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [89] Motion for Leave to Appear Pro Hac Vice Added Benjamin F. Jackson. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Dec 5, 2017	N/A	Notice of Rescheduling (0) Docket Text: ELECTRONIC NOTICE OF RESCHEDULING * AS TO TIME ONLY * Telephone Conference set for 12/5/2017 04:00 PM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Dec 5, 2017	N/A	Telephone Conference (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Telephone Conference held on 12/5/2017. Parties shall confer and report by close of business 12/7/2017. Parties ordered to reserve 1/30/2018-2/2/2018 for court scheduling purposes. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Casey, Cohen, Cutri, Fischer, Hales, Kelly, Klein, Martin) (Bono, Christine)
Dec 4, 2017	81	Main Document (23) Docket Text: MEMORANDUM in Opposition re [68] MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A)(Casey, Alison)
Dec 4, 2017	81	Exhibit A (9)
Dec 4, 2017	82	Motion to Seal (3) Docket Text: MOTION to Seal Janssen's Memorandum in Opposition to Defendants' Motion to Certify Order Denying Motion to Dismiss for Lack of Standing Under 28 U.S.C. § 1292(b) and Contingent Motion for Stay Pending Appeal (Dkt. No. 81) by Janssen Biotech, Inc..(Casey, Alison)
Dec 4, 2017	83	Notice of Manual Filing (3) Docket Text: NOTICE OF MANUAL FILING by Janssen Biotech, Inc. re [81] Memorandum in Opposition to Motion to Certify Order Denying Motion to Dismiss for Lack of Standing Under 28 U.S.C. § 1292(b) and Contingent Motion for Stay Pending Appeal (Casey, Alison)
Dec 4, 2017	85	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [82] Motion to Seal (Bono, Christine)
Dec 1, 2017	80	Motion for Extension of Time (4) Docket Text: Assented to MOTION for Extension of Time to December 7, 2017 to Respond to Defendants' Counterclaims by Janssen Biotech, Inc..(Casey, Alison)
Nov 28, 2017	75	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [70] Motion to Seal (Bono, Christine)
Nov 28, 2017	76	Order on Motion for Miscellaneous Relief (1) Docket Text: Judge Mark L. Wolf: "ALLOWED. The conference shall be held on December 5, 2017, at 3:30 p.m." ENDORSED ORDER entered granting [74] Motion Reschedule Telephone Conference (Bono, Christine)
Nov 28, 2017	77	Order on Motion for Extension of Time (1) Docket Text: Judge Mark L. Wolf: "As the court intends to hear argument on the motion on December 5, 2017, plaintiff's response shall be filed by 10:00 a.m. on December 4, 2017." ENDORSED ORDER entered granting in part and denying in part [73] Motion for Extension of Time (Bono, Christine)
Nov 28, 2017	N/A	Notice of Rescheduling (0) Docket Text: ELECTRONIC NOTICE OF RESCHEDULING Telephone Conference set for 12/5/2017 03:30 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to participants separately by the Deputy Clerk.(Bono, Christine)
Nov 27, 2017	74	Motion for Miscellaneous Relief (3) Docket Text: Assented to MOTION Plaintiff's Assented-to Motion to Reschedule December 4 Telephone Conference by Janssen Biotech, Inc..(Casey, Alison)
Nov 21, 2017	73	Motion for Extension of Time (3) Docket Text: Assented to MOTION for Extension of Time to December 7, 2017 to File Plaintiff's Opposition to Defendants' Motion to Certify Order Denying Motion to Dismiss and Contingent Motion for Stay Pending Appeal (Dkt. No. 68) by Janssen Biotech, Inc..(Casey, Alison)
Nov 17, 2017	70	Motion to Seal (3) Docket Text: Joint MOTION to Seal re: Joint Report and Exhibit by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Nov 17, 2017	71	Main Document (16) Docket Text: STATUS REPORT by Celltrion Healthcare Co., Ltd.. (Attachments: # (1) Exhibit A Redacted)(Martin, Andrea)
Nov 17, 2017	71	Exhibit A Redacted (2)
Nov 14, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [65] Motion for Leave to Appear Pro Hac Vice Added Gregory B. Sanford. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Nov 14, 2017	67	Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, with Jury Demand , COUNTERCLAIM against Janssen Biotech, Inc. by Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd..(Martin, Andrea)
Nov 14, 2017	68	Motion for Leave to Appeal (4) Docket Text: MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Nov 14, 2017	69	Memorandum in Support of Motion (21) Docket Text: MEMORANDUM in Support re [68] MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Nov 10, 2017	65	Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for admission of Gregory B. Sanford Filing fee: $ 100, receipt number 0101-6880807 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Certificate of Gregory B. Sanford in Support of Assented to Motion for Admission Pro Hac Vice)(Martin, Andrea)
Nov 10, 2017	65	Certificate of Gregory B. Sanford in Support of Assented to Motion for Admissio (2)
Oct 31, 2017	62	Memorandum & ORDER (34) Docket Text: Judge Mark L. Wolf: ORDER entered. MEMORANDUM AND ORDER. (Bono, Christine)
Oct 31, 2017	63	Order (2) Docket Text: Judge Mark L. Wolf: ORDER entered. (Bono, Christine)
Oct 31, 2017	N/A	Notice of Hearing (0) Docket Text: ELECTRONIC NOTICE of Hearing. Telephone Conference set for 12/4/2017 02:30 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to psrticipants separately by the Deputy Clerk. (Bono, Christine)
Oct 20, 2017	60	Status Report (8) Docket Text: STATUS REPORT (CORRECTED) Regarding Pending Motions by Janssen Biotech, Inc.. (Repicky, Heather)
Oct 19, 2017	N/A	Notice of Manual Filing (0) Docket Text: NOTICE OF MANUAL FILING Courtesy copy # 53 received and forwarded to chambers by Janssen Biotech, Inc. re [53] Memorandum in Opposition to Motion (Bono, Christine)
Oct 19, 2017	58	Status Report (14) Docket Text: STATUS REPORT regarding Pending Motions by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea)
Oct 19, 2017	59	Status Report (8) Docket Text: STATUS REPORT Regarding Pending Motions by Janssen Biotech, Inc.. (Repicky, Heather)
Oct 18, 2017	N/A	Notice of Manual Filing (0) Docket Text: NOTICE OF MANUAL FILING: Courtesy copy #[52] received and forwarded to chambers by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Franklin, Yvonne)
Oct 16, 2017	52	Main Document (32) Docket Text: BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to [13] MOTION to Dismiss for Lack of Jurisdiction Lack of StandingSupplemental Brief on Judicial Estoppel. (Attachments: # (1) Appendix C, # (2) Exhibit 37, # (3) Exhibit 38, # (4) Exhibit 39, # (5) Exhibit 40, # (6) Exhibit 41, # (7) Exhibit 42, # (8) Exhibit 43, # (9) Exhibit 44, # (10) Exhibit 45, # (11) Exhibit 46, # (12) Exhibit 47, # (13) Exhibit 48)(Martin, Andrea)
Oct 16, 2017	52	Appendix C (6)
Oct 16, 2017	52	Exhibit 37 (25)
Oct 16, 2017	52	Exhibit 38 (9)
Oct 16, 2017	52	Exhibit 39 (8)
Oct 16, 2017	52	Exhibit 40 (3)
Oct 16, 2017	52	Exhibit 41 (9)
Oct 16, 2017	52	Exhibit 42 (13)
Oct 16, 2017	52	Exhibit 43 (5)
Oct 16, 2017	52	Exhibit 44 (41)
Oct 16, 2017	52	Exhibit 45 (2)
Oct 16, 2017	52	Exhibit 46 (8)
Oct 16, 2017	52	Exhibit 47 (3)
Oct 16, 2017	52	Exhibit 48 (15)
Oct 16, 2017	53	Main Document (25) Docket Text: MEMORANDUM in Opposition re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of StandingSupplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # (1) Appendix A, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9)(Repicky, Heather)
Oct 16, 2017	53	Appendix A (8)
Oct 16, 2017	53	Exhibit 1 (9)
Oct 16, 2017	53	Exhibit 2 (84)
Oct 16, 2017	53	Exhibit 3 (16)
Oct 16, 2017	53	Exhibit 4 (36)
Oct 16, 2017	53	Exhibit 5 (16)
Oct 16, 2017	53	Exhibit 6 (28)
Oct 16, 2017	53	Exhibit 7 (7)
Oct 16, 2017	53	Exhibit 8 (3)
Oct 16, 2017	53	Exhibit 9 (9)
Oct 16, 2017	54	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Supplement Brief of Judicial Estoppel [Dkt 52] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Oct 13, 2017	N/A	Notice Cancelling Hearing (0) Docket Text: ELECTRONIC NOTICE Canceling 10/13/17 Motion Hearing. Associated Cases: 1:15-cv-10698-MLW, 1:14-cv-11613-MLW, 1:16-cv-11117-MLW, 1:17-cv-11008-MLW(Bono, Christine)
Oct 12, 2017	N/A	Motion Hearing (0) Docket Text: Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 10/12/2017 re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibits 1-7 entered. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Cutri, Diskant, Fischer, Frank, Friedman, Harris, Hurst, Kelly, Klein, Martin, Repicky) (Bono, Christine) Modified to reflect correct date on 10/30/2017 (Bono, Christine).
Oct 4, 2017	N/A	Order on Motion to Seal Document (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [43] Motion to Seal Document (Bono, Christine)
Oct 2, 2017	N/A	Notice of Manual Filing (0) Docket Text: NOTICE OF MANUAL FILING (Courtesy Copy) by Celltrion Healthcare Co., Ltd. (Franklin, Yvonne)
Sep 29, 2017	48	Notice of Manual Filing (1) Docket Text: NOTICE OF MANUAL FILING by Janssen Biotech, Inc. - Request for courtesy copy re: #[26] and #[42]. Forwarded to chambers. (Franklin, Yvonne)
Sep 11, 2017	44	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [17] Motion to Seal (Bono, Christine)
Sep 11, 2017	45	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [34] Motion to Seal (Bono, Christine)
Sep 11, 2017	46	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: ENDORSED ORDER entered granting [39] Motion to Seal (Bono, Christine)
Sep 8, 2017	42	Sur-Reply to Motion (30) Docket Text: SUR-REPLY to Motion re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing(Redacted) filed by Janssen Biotech, Inc.. (Casey, Alison)
Sep 8, 2017	43	Motion to Seal Document (3) Docket Text: Assented to MOTION to Seal Document [42] Sur-Reply to Motion by Janssen Biotech, Inc..(Casey, Alison)
Aug 29, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [37] Motion for Leave to Appear Pro Hac Vice Added Irena Royzman, David Kleban. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Aug 25, 2017	37	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Irena Royzman, David Kleban Filing fee: $ 200, receipt number 0101-6768305 by Janssen Biotech, Inc.. (Attachments: # (1) Certificate of Irena Royzman, # (2) Certificate of David Kleban)(Casey, Alison)
Aug 25, 2017	37	Certificate of Irena Royzman (1)
Aug 25, 2017	37	Certificate of David Kleban (1)
Aug 25, 2017	38	Main Document (41) Docket Text: REPLY to Response to [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing[Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Appendix B, # (2) Exhibit 32, # (3) Exhibit 33, # (4) Exhibit 34, # (5) Exhibit 35, # (6) Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne).
Aug 25, 2017	38	Appendix B (1)
Aug 25, 2017	38	Exhibit 32 (3)
Aug 25, 2017	38	Exhibit 33 (3)
Aug 25, 2017	38	Exhibit 34 (36)
Aug 25, 2017	38	Exhibit 35 (112)
Aug 25, 2017	38	Exhibit 36 (28)
Aug 25, 2017	39	Motion to Seal (3) Docket Text: Assented to MOTION to Seal re: Reply in support of Motion to Dismiss by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Aug 21, 2017	33	Main Document (24) Docket Text: STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Martin, Andrea)
Aug 21, 2017	33	Exhibit 1 (37)
Aug 21, 2017	33	Exhibit 2 (1)
Aug 21, 2017	33	Exhibit 3 (1)
Aug 21, 2017	33	Exhibit 4 (1)
Aug 21, 2017	33	Exhibit 5 (16)
Aug 21, 2017	33	Exhibit 6 (12)
Aug 21, 2017	33	Exhibit 7 (23)
Aug 21, 2017	33	Exhibit 8 (14)
Aug 21, 2017	34	Motion to Seal (4) Docket Text: Assented to MOTION to Seal re: Joint Report by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Aug 7, 2017	31	Order on Motion to Seal (1) Docket Text: Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting [25] Motion to Seal (Bono, Christine)
Aug 7, 2017	32	Order (5) Docket Text: Judge Mark L. Wolf: ORDER entered. Associated Cases: 1:15-cv-10698-MLW, 1:16-cv-11117-MLW, 1:17-cv-11008-MLW(Bono, Christine)
Aug 2, 2017	25	Motion to Seal (3) Docket Text: Assented to MOTION to Seal Janssen's Opposition to Defendants' Motion to Dismiss for Lack of Standing and Supporting Exhibits by Janssen Biotech, Inc..(Casey, Alison)
Aug 2, 2017	26	Main Document (38) Docket Text: Opposition re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing(Redacted) filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit 1 (Filed Under Seal), # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4 (Filed Under Seal), # (5) Exhibit 5)(Casey, Alison)
Aug 2, 2017	26	Exhibit 1 (Filed Under Seal) (1)
Aug 2, 2017	26	Exhibit 2 (4)
Aug 2, 2017	26	Exhibit 3 (23)
Aug 2, 2017	26	Exhibit 4 (Filed Under Seal) (1)
Aug 2, 2017	26	Exhibit 5 (4)
Aug 2, 2017	27	Main Document (7) Docket Text: AFFIDAVIT of Kenneth Dow in Opposition re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I (Filed Under Seal))(Casey, Alison)
Aug 2, 2017	27	Exhibit A (15)
Aug 2, 2017	27	Exhibit B (26)
Aug 2, 2017	27	Exhibit C (4)
Aug 2, 2017	27	Exhibit D (7)
Aug 2, 2017	27	Exhibit E (6)
Aug 2, 2017	27	Exhibit F (6)
Aug 2, 2017	27	Exhibit G (13)
Aug 2, 2017	27	Exhibit H (25)
Aug 2, 2017	27	Exhibit I (Filed Under Seal) (1)
Aug 2, 2017	28	Affidavit in Opposition to Motion (7) Docket Text: AFFIDAVIT of Katherine Amos in Opposition re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Casey, Alison)
Aug 1, 2017	19	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Affidavit Certificate of Elizabeth Cutri, # (2) Affidavit Certificate of Bryan S. Hales, # (3) Affidavit Certificate of James F. Hurst, # (4) Affidavit Certificate of James H. McConnell, # (5) Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne).
Aug 1, 2017	19	Affidavit Certificate of Elizabeth Cutri (2)
Aug 1, 2017	19	Affidavit Certificate of Bryan S. Hales (2)
Aug 1, 2017	19	Affidavit Certificate of James F. Hurst (2)
Aug 1, 2017	19	Affidavit Certificate of James H. McConnell (2)
Aug 1, 2017	19	Affidavit Certificate of Ryan Kane (2)
Aug 1, 2017	20	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Charles Klein, Dan Hoang, Samuel Park Filing fee: $ 300, receipt number 0101-6734845 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Affidavit Certificate of Charles B. Klein, # (2) Affidavit Certificate of Dan H. Hoang, # (3) Affidavit Certificate of Samuel Park)(Martin, Andrea)
Aug 1, 2017	20	Affidavit Certificate of Charles B. Klein (2)
Aug 1, 2017	20	Affidavit Certificate of Dan H. Hoang (2)
Aug 1, 2017	20	Affidavit Certificate of Samuel Park (2)
Aug 1, 2017	21	Main Document (2) Docket Text: Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # (1) Affidavit Certificate of Gregory L. Diskant, # (2) Affidavit Certificate of Aron Fischer, # (3) Affidavit Certificate of Andrew D. Cohen, # (4) Affidavit Certificate of Daniel A. Friedman)(Casey, Alison)
Aug 1, 2017	21	Affidavit Certificate of Gregory L. Diskant (1)
Aug 1, 2017	21	Affidavit Certificate of Aron Fischer (1)
Aug 1, 2017	21	Affidavit Certificate of Andrew D. Cohen (1)
Aug 1, 2017	21	Affidavit Certificate of Daniel A. Friedman (1)
Aug 1, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [19] Motion for Leave to Appear Pro Hac Vice Added Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Aug 1, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [20] Motion for Leave to Appear Pro Hac Vice Added Charles B. Klein, Dan H. Hoang, Samuel S. Park. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Aug 1, 2017	N/A	Order on Motion for Leave to Appear (0) Docket Text: Judge Mark L. Wolf: ELECTRONIC ORDER entered granting [21] Motion for Leave to Appear Pro Hac Vice Added Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne)
Jul 12, 2017	18	Restricted (0) Docket Text: SEALED UNREDACTED DOCUMENTS RE: [13] (Attachments: # (1) Appendix A, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 6, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 20, # (9) Exhibit 21, # (10) Exhibit 23, # (11) Exhibit 26, # (12) Exhibit 27, # (13) Exhibit 28)(14) Cover Letter) (Franklin, Yvonne).
Jul 12, 2017	18	Restricted (0)
Jul 12, 2017	18	Restricted (0)
Jul 12, 2017	18	Restricted (0)
Jul 12, 2017	18	Restricted (0)
Jul 12, 2017	18	Exhibit 10 (8)
Jul 12, 2017	18	Exhibit 11 (7)
Jul 12, 2017	18	Exhibit 12 (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 12, 2017	18	Restricted (16)
Jul 11, 2017	9	Notice of Appearance (2) Docket Text: NOTICE of Appearance by Dennis J. Kelly on behalf of Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Kelly, Dennis)
Jul 11, 2017	10	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Andrea L. Martin on behalf of Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Martin, Andrea)
Jul 11, 2017	11	Corporate Disclosure Statement (3) Docket Text: CORPORATE DISCLOSURE STATEMENT by Celltrion Healthcare Co., Ltd., Celltrion, Inc.. (Martin, Andrea)
Jul 11, 2017	12	Corporate Disclosure Statement (3) Docket Text: CORPORATE DISCLOSURE STATEMENT by Hospira, Inc. identifying Corporate Parent Pfizer, Inc. for Hospira, Inc... (Martin, Andrea)
Jul 11, 2017	13	Motion to Dismiss/Lack of Jurisdiction (3) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Lack of Standing by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jul 11, 2017	14	Main Document (39) Docket Text: MEMORANDUM in Support re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Appendix A (Redacted))(Martin, Andrea)
Jul 11, 2017	14	Appendix A (Redacted) (12)
Jul 11, 2017	15	Main Document (15) Docket Text: ADDENDUM re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing[Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 5, # (5) Exhibit 6, # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 9, # (9) Exhibit 10, # (10) Exhibit 11, # (11) Exhibit 12, # (12) Exhibit 13, # (13) Exhibit 14, # (14) Exhibit 15, # (15) Exhibit 16)(Martin, Andrea)
Jul 11, 2017	15	Exhibit 2 (1)
Jul 11, 2017	15	Exhibit 3 (1)
Jul 11, 2017	15	Exhibit 4 (30)
Jul 11, 2017	15	Exhibit 5 (23)
Jul 11, 2017	15	Exhibit 6 (1)
Jul 11, 2017	15	Exhibit 7 (62)
Jul 11, 2017	15	Exhibit 8 (34)
Jul 11, 2017	15	Exhibit 9 (29)
Jul 11, 2017	15	Exhibit 10 (1)
Jul 11, 2017	15	Exhibit 11 (1)
Jul 11, 2017	15	Exhibit 12 (1)
Jul 11, 2017	15	Exhibit 13 (42)
Jul 11, 2017	15	Exhibit 14 (26)
Jul 11, 2017	15	Exhibit 15 (26)
Jul 11, 2017	15	Exhibit 16 (8)
Jul 11, 2017	16	Main Document (7) Docket Text: ADDENDUM re [13] MOTION to Dismiss for Lack of Jurisdiction Lack of Standing[Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22, # (6) Exhibit 23, # (7) Exhibit 24, # (8) Exhibit 25, # (9) Exhibit 26, # (10) Exhibit 27, # (11) Exhibit 28, # (12) Exhibit 29, # (13) Exhibit 30, # (14) Exhibit 31)(Martin, Andrea)
Jul 11, 2017	16	Exhibit 18 (3)
Jul 11, 2017	16	Exhibit 19 (16)
Jul 11, 2017	16	Exhibit 20 (1)
Jul 11, 2017	16	Exhibit 21 (1)
Jul 11, 2017	16	Exhibit 22 (17)
Jul 11, 2017	16	Exhibit 23 (1)
Jul 11, 2017	16	Exhibit 24 (1)
Jul 11, 2017	16	Exhibit 25 (10)
Jul 11, 2017	16	Exhibit 26 (1)
Jul 11, 2017	16	Exhibit 27 (1)
Jul 11, 2017	16	Exhibit 28 (1)
Jul 11, 2017	16	Exhibit 29 (52)
Jul 11, 2017	16	Exhibit 30 (24)
Jul 11, 2017	16	Exhibit 31 (25)
Jul 11, 2017	17	Motion to Seal (4) Docket Text: Assented to MOTION to Seal re Motion to Dismiss by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea)
Jun 1, 2017	2	Civil Cover Sheet (1)
Jun 1, 2017	3	Category Form (1)
Jun 1, 2017	N/A	Notice of Case Assignment (0) Docket Text: ELECTRONIC NOTICE of Case Assignment. Judge Mark L. Wolf assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Judith G. Dein. (Abaid, Kimberly)
Jun 1, 2017	6	Summons Issued (2) Docket Text: Summons Issued as to Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (DaSilva, Carolina)
Jun 1, 2017	7	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Alison C. Casey on behalf of Janssen Biotech, Inc. (Casey, Alison) (Main Document 7 replaced and modified on 6/8/2017) to correct plaintiffs name (Franklin, Yvonne).
Jun 1, 2017	8	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Heather B. Repicky on behalf of Janssen Biotech, Inc. (Repicky, Heather) (Main Document 8 replaced and modified on 6/8/2017) to correct plaintiffs name (Franklin, Yvonne).
May 31, 2017	1	Main Document (33) Docket Text: COMPLAINT against Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd. Filing fee: $ 400, receipt number 0101-6651700 (Fee Status: Filing Fee paid), filed by Janssen Biotech, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) Category Form)(Casey, Alison) (Main Document 1 replaced to include correct Atty. signature on 6/1/2017) (Franklin, Yvonne).
May 31, 2017	1	Exhibit A (12)
May 31, 2017	3	Corporate Disclosure Statement (2) Docket Text: CORPORATE DISCLOSURE STATEMENT by Janssen Biotech, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc... (Casey, Alison)
May 31, 2017	4	Notice of Appearance (0) Docket Text: NOTICE of Appearance by Alison C. Casey on behalf of Janssen Biotech, Inc. (Casey, Alison) Modified on 6/1/2017 document removed. Filer refiled with correct Atty. name at D.E. #7 (Franklin, Yvonne).
May 31, 2017	1	Civil Cover Sheet (1)
May 31, 2017	1	Category Form (1)
May 31, 2017	2	Report on the filing/termination of patent/trademark case (1) Docket Text: REPORT ON THE FILING/TERMINATION OF AN ACTION REGARDING PATENT OR TRADEMARK. (Casey, Alison)
May 31, 2017	1	Complaint* (1)

Lawsuits

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd. et al > Documents